Search Within

Siddharth Kunte

Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (4)
  4. Department of Pathology and Laboratory Medicine (3)
  5. GSK Faculty (3)
  6. Human Oncology and Pathogenesis Program (3)

More Groups

People
  1. Elisa De Stanchina (3)
  2. Igor Odintsov (3)
  3. Lukas Delasos (3)
  4. Marc Ladanyi (3)
  5. Marissa Mattar (3)
  6. Morana Vojnic (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2018 (2)
  5. 2017 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Disease Models & Mechanisms (2)
  3. Journal of Bone Oncology (1)
  4. Nature Cancer (1)
  5. Translational Lung Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Company of Biologists (2)
  3. Elsevier Inc. (1)
  4. Nature Research (1)
  5. Translational Lung Cancer Research (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
    Journal Article

    Miyazaki, I.; Odintsov, I.; Ishida, K.; Lui, A. J. W.; Kato, M.; Suzuki, T.; Zhang, T.; Wakayama, K.; Kurth, R. I.; Cheng, R.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
    Journal Article

    Smith, R. S.; Odintsov, I.; Liu, Z.; Lui, A. J. W.; Hayashi, T.; Vojnic, M.; Suehara, Y.; Delasos, L.; Mattar, M. S.; Hmeljak, J.; more...
    Disease Models & Mechanisms (2022)

    Fulltext@MSK | Save
  • RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation
    Journal Article

    Hayashi, T.; Odintsov, I.; Smith, R. S.; Ishizawa, K.; Liu, A. J. W.; Delasos, L.; Kurzatkowski, C.; Tai, H.; Gladstone, E.; Vojnic, M.; more...
    Disease Models & Mechanisms (2021)

    Fulltext@MSK | Save
  • Survival outcomes among young small cell lung cancer (SCLC) patients and insurance status: A SEER analysis 2007-2014
    Meeting Abstract

    Wang, Q.; Zhang, Y.; Jiang, C.; Kunte, S.; Gupta, M.; Deng, L.; Xiao, Z.; Liu, Y.; Perimbeti, S.; Daly, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Insurance disparity and outcomes among younger non-small cell lung cancer (NSCLC) patients: A SEER analysis 2007-2014
    Meeting Abstract

    Wang, Q.; Jiang, C.; Zhang, Y.; Kunte, S.; Deng, L.; Liu, Y.; Xiao, Z.; Perimbeti, S.; Daly, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Early-onset pancreatic ductal adenocarcinoma (PDAC) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Kunte, S.; Sangli, S.; Lemor, A.; Lowery, M. A.; Yu, K. H.; Abou-Alfa, G. K.; Varghese, A. M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: Time to move on to better biomarkers?
    Journal Article

    Santini, F. C.; Kunte, S.; Drilon, A.
    Translational Lung Cancer Research (2017)

    Fulltext@MSK | Save
  • Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score
    Journal Article

    Mariotti, V.; Page, D. B.; Davydov, O.; Hans, D.; Hudis, C. A.; Patil, S.; Kunte, S.; Girotra, M.; Farooki, A.; Fornier, M. N.
    Journal of Bone Oncology (2017)

    Fulltext@MSK | Save